CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Clinical Studies
Original article

KORTUC Achieves Target Enrollment in Registrational Breast Cancer Trial as Three Global Clinical Programs Advance

Trial StartK-BOOSTPositive
AI Analysis

Summary

KORTUC achieved target enrollment of 184 patients in its registrational breast cancer trial and is advancing cervical cancer studies with UC San Diego and a newly authorized K-BOOST rectal cancer program.

Clinical Trial Data

Phase

registrational

Patients

184

Importance:6/10
Sentiment:
0.70
breast cancercervical cancerrectal cancerclinical trialenrollmentregistrational
Related Companies

Read the original article

Published by GlobeNewswire Clinical Studies on September 15, 2026 1:00 PM

Read Original